IBM · 1 day ago
Intern 2026: AI-based forecasting of molecular interactions
IBM Research is dedicated to technology and its societal impact, inviting you to be part of a team that shapes the future of computing. As an intern, you will analyze data using machine learning techniques to forecast molecular interactions, contributing to research reports and presentations.
Business DevelopmentBusiness Information SystemsCRMData ManagementSoftware
Responsibilities
Analyze the already collected data by building your own codes or using standard ML tools for analyzing time series from atomistic simulations
Study the different contacts that the four Wnt proteins make with Wls, highlighting the contact network and how this shapes the protein-protein interaction
Contribute to designing the analysis of the simulations and making improvements to the current status of the project
Contribute to write a research report or paper on your internship project and present your work at internal research meetings and/or external workshops and/or conferences
Qualification
Required
Background in Computer Science, Machine Learning, Biochemistry, or a related field
Proficiency in Python, and technologies like TensorFlow, PyTorch, CUDA, and Ray
Familiarity with high-performance computing environments, and DevOps tools (GitHub)
Preferred
Demonstrating the ability to conduct and communicate impactful research and of working in teams
Experience in knowledge engineering, machine learning, and scientific software development
Company
IBM
IBM is an IT technology and consulting firm providing computer hardware, software, infrastructure, and hosting services.
H1B Sponsorship
IBM has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3032)
2024 (3301)
2023 (2160)
2022 (1809)
2021 (1157)
2020 (2669)
Funding
Current Stage
Public CompanyTotal Funding
unknown2011-01-14IPO
Leadership Team
Recent News
2026-01-03
2026-01-03
Company data provided by crunchbase